How is UnitedHealth Using AI & Sustainability in Healthcare?

To date, UnitedHealthcare works with more than 1.7 million physicians and care professionals, as well as more than 7,000 hospitals and care facilities to aid in providing quality care where it's needed.

Founded in 1980, UnitedHealthcare offers a broad range of services to millions of individuals while also adventuring into sustainable practices.

“During a major life event, no one should have to wonder whether they’re eligible for a benefit or spend time digging through paperwork,” said Steve Wilson, CEO, Speciality Benefits, at UnitedHealthcare.

According to UnitedHealth Group, AI is transforming healthcare by improving access, supporting clinicians and delivering timely, personalised interventions for patients. 

AI tools help patients find the right providers, understand costs, receive real-time benefits and pharmacy answers and get proactive guidance, such as alerts for missed prescriptions. 

How J&J is Tackling The World’s Toughest Health Challenges

For more than 140 years, Johnson & Johnson (J&J) has been at the forefront of healthcare innovation, committed to keeping people well at every age and stage of life.

From its beginnings at the 1876 World’s Fair to pioneering breakthroughs in medicine, medical technologies and public health, J&J has helped to shape modern healthcare.

Its rich history is filled with iconic products, visionary leaders and a continuous drive to improve the health and lives of people worldwide.

“At Johnson & Johnson, we are leading where medicine is going, with a relentless focus on bringing transformational medical innovation to patients who are waiting,” says Jennifer L. Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine, Johnson & Johnson.

McKesson: Advancing Sustainable Healthcare & Supply Chains

McKesson is a diversified healthcare services leader dedicated to advancing health outcomes for patients, providers and the broader healthcare ecosystem. 

Touching nearly every aspect of health, the company connects products, partners and people to ensure medications, therapies and medical supplies reach patients safely and efficiently.

Through its robust network of more than 50 distribution centres, McKesson delivers more than a third of all medications in the US, offering more than 300,000 national brand and proprietary products. 

Its capabilities span pharmaceutical and medical-surgical distribution, pharmacy services, oncology and multispecialty solutions, biopharma support and prescription benefit programs, all designed to improve access, affordability and adherence.

AS Watson: Cutting Plastic from Health and Beauty Packaging

AS Watson operates as the world's largest international health and beauty retailer, managing 12 retail brands that span 31 markets globally.

The retailer's strategy centres on merging offline and online retail channels, creating a unified shopping experience for its 180 million loyalty programme members.

The business has reinforced its environmental pledges, setting an objective to cut virgin plastic usage by 21%.

The retailer's plastic reduction ambition encompasses a renewed commitment to decrease virgin plastic in own brand packaging by 21% by 2030, measured against a 2022 baseline.

How AstraZeneca is Advancing Treatment Discovery in China

AstraZeneca has announced a landmark US$15bn investment in China through 2030, aimed at expanding its medicines manufacturing and R&D capabilities in one of its most strategically important markets.

The company said the investment will strengthen its ability to discover, develop and manufacture transformative new treatments, supporting the delivery of its 2030 ambition. 

It will also leverage China’s scientific expertise, advanced manufacturing capabilities and growing China-UK healthcare ecosystem collaborations to bring therapies to patients in China and around the world.